Product ID: SQSG35A2033
Report ID:
SQSG35A2033 |
Region:
Global |
Published Date: February, 2024
Pages:
165
|
Tables:
65 |
Figures:
75
In 2021, North America held the largest share of the global market and generated more than 40.7% of the total revenue. This is owing to increase in the number of elderly people, which raises the demand for intravenous solutions, the prevalence of chronic diseases, and the industry's expansion in response to the flu and coronavirus pandemic's increased demand. During the projection period, the Asia-Pacific region is anticipated to have the quickest CAGR.
The high rate of growth in this area can be attributed to the fact that both public and private organizations spend a lot of money on research, as well as to advancements in technology and an increase in partnerships between different groups of stakeholders, such as universities and the medical community. Additional important factors that are anticipated to fuel market growth in the Asia Pacific region include the rising prevalence of chronic diseases brought on by bad eating habits and the rising desire for cost-effective treatments.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONIntravenous IV Fluid Bags Market size was valued at USD 6 billion in 2019 and is poised to grow from USD 6.21 billion in 2023 to USD 9.2 billion by 2031, growing at a CAGR of 4.9% in the forecast period (2024-2031).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQSG35A2033